Immix Biopharma (IMMX) Change in Accured Expenses (2021 - 2026)
Quarterly results put Change in Accured Expenses at $432207.0 for Q1 2026, up 67.06% from a year ago — trailing twelve months through Mar 2026 was $1.2 million (down 56.11% YoY), and the annual figure for FY2025 was $1.0 million, down 76.66%.
Immix Biopharma has reported Change in Accured Expenses over the past 6 years, most recently at $432207.0 for Q1 2026.
- Change in Accured Expenses reached $432207.0 in Q1 2026 per IMMX's latest filing, up from -$790864.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.3 million in Q4 2024 and bottomed at -$1.8 million in Q2 2024.
- Median Change in Accured Expenses over the past 5 years was $451957.0 (2023), compared with a mean of $552423.9.
- Peak annual rise in Change in Accured Expenses hit 908.74% in 2024, while the deepest fall reached 292.53% in 2024.
- Over 5 years, Change in Accured Expenses stood at -$170024.0 in 2022, then surged by 602.41% to $854219.0 in 2023, then soared by 167.04% to $2.3 million in 2024, then plummeted by 134.67% to -$790864.0 in 2025, then skyrocketed by 154.65% to $432207.0 in 2026.
- Business Quant data shows Change in Accured Expenses for IMMX at $432207.0 in Q1 2026, -$790864.0 in Q4 2025, and $1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 107.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 432,207.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 432,207.00 |
| Mar 31, 2026 | 432,207.00 |
| Dec 31, 2025 | -790,864.00 |
| Dec 31, 2025 | -790,864.00 |
| Sep 30, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 524,186.00 |
| Jun 30, 2025 | 524,186.00 |
| Mar 31, 2025 | 258,718.00 |
| Mar 31, 2025 | 258,718.00 |
| Dec 31, 2024 | 2.28 Mn |
| Dec 31, 2024 | 2.28 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | -1.80 Mn |
| Jun 30, 2024 | -1.80 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 854,219.00 |
| Dec 31, 2023 | 854,219.00 |
| Sep 30, 2023 | 451,957.00 |
| Sep 30, 2023 | 451,957.00 |
| Jun 30, 2023 | 937,485.00 |
| Jun 30, 2023 | 937,485.00 |
| Mar 31, 2023 | 190,806.00 |
| Mar 31, 2023 | 190,806.00 |
| Jun 30, 2022 | -170,024.00 |
| Jun 30, 2022 | -170,024.00 |
| Mar 31, 2022 | 160,925.00 |
| Mar 31, 2022 | 160,925.00 |
| Dec 31, 2021 | -80,680.00 |
| Dec 31, 2021 | -80,680.00 |
| Sep 30, 2021 | 140,905.00 |
| Sep 30, 2021 | 140,905.00 |
| Jun 30, 2021 | 201,918.00 |
| Jun 30, 2021 | 201,918.00 |
| Mar 31, 2021 | -141,989.00 |
| Mar 31, 2021 | -141,989.00 |